Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.08 USD | +0.57% | +26.20% | -20.09% |
May. 17 | North American Morning Briefing : The "Everything -2- | DJ |
May. 16 | Citigroup Upgrades Prime Medicine at Buy From Neutral With $10 Price Target | MT |
Financials (USD)
Sales 2024 * | 4.76M | Sales 2025 * | 3.99M | Capitalization | 819M |
---|---|---|---|---|---|
Net income 2024 * | -193M | Net income 2025 * | -216M | EV / Sales 2024 * | 156 x |
Net cash position 2024 * | 76.98M | Net cash position 2025 * | 205M | EV / Sales 2025 * | 154 x |
P/E ratio 2024 * |
-4.2
x | P/E ratio 2025 * |
-4.66
x | Employees | 234 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 73.52% |
Latest transcript on Prime Medicine, Inc.
1 day | +0.57% | ||
1 week | +26.20% | ||
Current month | +43.90% | ||
1 month | +43.61% | ||
3 months | -16.31% | ||
6 months | +7.27% | ||
Current year | -20.09% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 70 | 20-06-30 | |
Allan Reine
DFI | Director of Finance/CFO | 49 | Jan. 16 |
Chief Operating Officer | 52 | 22-08-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 64 | 21-11-30 | |
Robert Nelsen
BRD | Director/Board Member | 60 | 20-08-31 |
Michael Kelly
BRD | Director/Board Member | 67 | 21-10-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
4.71% | 2 M€ | -25.75% | ||
0.00% | 9 M€ | +11.05% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-17 | 7.08 | +0.57% | 610,441 |
24-05-16 | 7.04 | +4.14% | 847,000 |
24-05-15 | 6.76 | +1.50% | 537,933 |
24-05-14 | 6.66 | +3.74% | 842,888 |
24-05-13 | 6.42 | +14.44% | 1,408,568 |
Delayed Quote Nasdaq, May 17, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-20.09% | 819M | |
+9.42% | 115B | |
+11.84% | 106B | |
-14.15% | 21.84B | |
-1.05% | 21.96B | |
-5.29% | 19.21B | |
-38.29% | 17.71B | |
-4.16% | 18.08B | |
+7.99% | 14.32B | |
+36.24% | 12.42B |
- Stock Market
- Equities
- PRME Stock